Personal information

Activities

Works (12)

A novel bioassay to detect Nociceptin/Orphanin FQ release from single human polymorphonuclear cells

PLOS ONE
2022-05-27 | Journal article
Contributors: M. F. Bird; Hubert Vaudry; C. P. Hebbes; S. W. M. Scott; J. Willets; J. P. Thompson; D. G. Lambert
Source: check_circle
Crossref

Non-opioid analgesics

Anaesthesia & Intensive Care Medicine
2016-09 | Journal article
Contributors: Christopher Hebbes
Source: Self-asserted source
Christopher Hebbes via Crossref Metadata Search

Drugs acting on the heart: anti-arrhythmics

Anaesthesia & Intensive Care Medicine
2015-05 | Journal article
Contributors: Christopher Hebbes; Jonathan P. Thompson
Source: Self-asserted source
Christopher Hebbes via Crossref Metadata Search

The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.

2013 | Journal article
Contributors: Brookes ZL; Stedman EN; Brown NJ; Hebbes CP; Guerrini R; Calo G; Reilly CS; Lambert DG
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central

The Nociceptin/Orphanin FQ Receptor Antagonist UFP-101 Reduces Microvascular Inflammation to Lipopolysaccharide In Vivo

PLoS ONE
2013-09 | Journal article
Contributors: Zoë L. S. Brookes; Emily N. Stedman; Nicola J. Brown; Christopher P. Hebbes; Remo Guerrini; Girolamo Calo; Charles S. Reilly; David G. Lambert; Ashlesh K Murthy
Source: Self-asserted source
Christopher Hebbes via Crossref Metadata Search

Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores.

2008-10 | Journal article
Contributors: Garcea G; Gouda M; Hebbes C; Ong SL; Neal CP; Dennison AR; Berry DP
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central

Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.

2007-06 | Journal article
Contributors: Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G et al.
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central

Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies

Peptides
2006 | Journal article
Contributors: Raffaella Vergura; Elena Valenti; Christopher P. Hebbes; Elaine C. Gavioli; Barbara Spagnolo; John McDonald; David G. Lambert; Gianfranco Balboni; Severo Salvadori; Domenico Regoli et al.
Source: Self-asserted source
Christopher Hebbes via Crossref Metadata Search

Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.

2006-12 | Journal article
Contributors: Vergura R; Valenti E; Hebbes CP; Gavioli EC; Spagnolo B; McDonald J; Lambert DG; Balboni G; Salvadori S; Regoli D et al.
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central

Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist

Bioorganic & Medicinal Chemistry
2006-02 | Journal article
Contributors: Claudio Trapella; Remo Guerrini; Laura Piccagli; Girolamo Calo’; Giacomo Carra’; Barbara Spagnolo; Samantha Rubini; Giulia Fanton; Christopher Hebbes; John McDonald et al.
Source: Self-asserted source
Christopher Hebbes via Crossref Metadata Search

Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist.

2006-02 | Journal article
Contributors: Trapella C; Guerrini R; Piccagli L; Calo' G; Carra' G; Spagnolo B; Rubini S; Fanton G; Hebbes C; McDonald J et al.
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.

2005-03 | Journal article
Contributors: Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D et al.
Source: Self-asserted source
Christopher Hebbes via Europe PubMed Central